Screening for Combination Cancer Therapies With Dynamic Fuzzy Modeling and Multi-Objective Optimization

Area of Science:

• Computational Biology
• Oncology
• Systems Biology

Background:

• Combination therapies enhance cancer treatment efficacy by increasing tumor cell death and reducing resistance.
• Identifying effective drug combinations typically requires extensive and costly in vitro experiments.

Purpose of the Study:

• To develop and validate a novel computational approach for efficient identification of cancer combination therapies.
• To reduce the time and cost associated with discovering new cancer treatment strategies.

Main Methods:

• Integration of dynamic fuzzy modeling with multi-objective optimization.
• Application of the computational approach to a model of oncogenic K-ras cancer cells with a Warburg effect.
• Validation against known cancer therapies for the selected cell model.

Main Results:

• The computational method successfully identified known combination therapies for K-ras cancer.
• The approach can suggest novel therapies involving a small number of molecular targets.
• Identified combinations of up to three targets affecting crucial cancer proliferation and survival pathways.

Conclusions:

• The novel computational approach offers an efficient and cost-effective strategy for discovering novel cancer combination therapies.
• This method holds promise for identifying targeted treatments for specific cancer types, such as K-ras cancers.
• The integration of dynamic fuzzy modeling and multi-objective optimization provides a powerful tool for cancer drug discovery.